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Background: Persistent hyperglycaemia is a hallmark of Diabetes Mellitus (DM). It causes increased production
of free radicals, especially reactive oxygen species (ROS), — resulting in oxidative stress. Reactive Oxygen Species
have been implicated in the development of haematological complications in patients with diabetes. Superoxide
Dismutase (SOD) is one of the most effective antioxidant enzyme defense systems against free radicals.
Methods: From February through May 2014, we assessed the relationship between oxidative stress and haematological
profiles among individuals with and without diabetes. A cross sectional study of 66 case patients and 44 age-matched
controls were recruited from the National Diabetes Management and Research Centre (NDMRC), Korle-Bu Teaching Hospital,
Accra, Ghana. Blood samples were obtained from study participants with consent. We determined the haematological
profiles of study participants and measured their oxidative stress levels using a standardized kit for SOD activity.
Results: Higher white blood cell (WBC) counts were seen in the diabetes cohort (p-value = 0.023). The SOD activity
tended to be lower in diabetes patients (p–value = 0.144 however) while higher neutrophil levels seemed to correlate
with SOD activity (R = 0.249; R2 = 6.2 %; p-value = 0.049). There did not appear to be a correlation between fasting
blood glucose (FBG) and SOD activity (R =−0.044; p-value = 0.727).
Conclusion: The study reports similar oxidative stress levels, as measured by SOD activity, in diabetic and non-diabetic
adults. The SOD activity did not appear to correlate with FBG and several other haematological parameters. Further
study would be required to investigate the relationship between these haematological indices and diabetic micro- and
macro-vascular complications in our population.
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Diabetes mellitus (DM) is major cause of adult morbid-
ity and death in Ghana — with an estimated prevalence
of 3.3 % that represents a diabetic population of 354,020
[1]. The disease is characterized by a deficiency in insu-
lin resulting in disturbances in carbohydrate, lipid and
protein metabolism, which manifest as chronic hyper-
glycaemia. Persistent hyperglycaemia in DM causes an
increased production of free radicals especially Reactive
Oxygen Species (ROS). Destruction mediated by such* Correspondence: rhasmah@chs.edu.gh
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creativecommons.org/publicdomain/zero/1.0/free radicals results in protein denaturation, DNA strand
breaks and alterations of cell membrane fluidity. Anti-
oxidant enzyme defense systems against free radicals
include superoxide dismutase (SOD) and catalase [2, 3].
Superoxide Dismutase is one of the most effective intra-
cellular enzymatic antioxidants that catalyzes the con-
version of superoxide (O2
−) to oxygen (O2) and to the
less reactive species, hydrogen peroxide (H2O2) [4, 5].
Reports indicate that antioxidants are either reduced or
not sufficient to eliminate ROS in diabetic patients lead-
ing to oxidative stress [6]. Oxidative stress results from
an imbalance between free radicals and the body’s anti-
oxidant defense systems; resulting in red blood cell dys-
function, platelet destruction and tissue injury. In patientsrticle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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of blood cells as well as the coagulation system leading to
complications such as anaemia, infection, and hypercoag-
ulability [7]. Yet, these haematological changes also opens
up the possibility that circulating blood cells, particularly
leukocytes including lymphocytes and neutrophils could
serve as biomarkers for oxidative stress, and as an index of
diagnostic significance in routine clinical evaluation of the
state of diabetes [8]. We conducted this study with a
two-fold primary objective. First, to determine whether
patients with diabetes have higher oxidative stress, and
second to evaluate the association between oxidative
stress and certain changes in hematological indices.
Methods
Study site
This study was carried out at the National Diabetes
Management and Research Centre (NDMRC), Accra,
Ghana. It serves as the Diabetes Clinic of the Korle-Bu
Teaching Hospital (KBTH). The KBTH is a 2000-bed
tertiary teaching hospital with about 200 admissions per
day. The hospital covers all medical specialties and pro-
vides referral healthcare services to an estimated popula-
tion of 24 million Ghanaians. The NDMRC is designed
to manage diabetic conditions of patients in Ghana. The
Centre also supports and enhances the national effort in
diabetes, its complications, and related endocrine and
metabolic diseases through interdisciplinary research.
Study population
The study population comprised Diabetes Mellitus pa-
tients aged 30 to 80 years who attended the NDMRC
and consented to participate in the study. A volunteer
group without Diabetes Mellitus and of the same age-
brackets were enrolled as controls.
Ethical approval
Ethical approval was obtained from the Ethics and
Protocol Review Committee of the School of Allied
Health Sciences, University of Ghana prior to the enrol-
ment of participants.
Study design
This was an analytical cross-sectional study with age-
matched comparison controls. The study was conducted
from February through May 2014. Two sampling ap-
proaches were used. First, an active case-finding network
was organized with visits to the NDMRC at Korle-Bu.
Physician-identified patients with known type-1 or type-
2 diabetes attending the center for review and manage-
ment of various diabetic conditions were referred to the
research team for screening and inclusion in the study
after informed consent was obtained. Diabetic patients
enrolled into the study were categorized as cases. Priorto enrollment, the nature, purpose and potential risks of
the study were explained to all subjects. Patients’ case
history was ascertained through physician-assisted re-
view of medical folders. Cases were recruited based on
the following screening criteria: 30–80 years of age, pre-
prandial capillary plasma glucose levels of 3.9 – 7.2 mmol/
l and mean plasma glucose of 8.6 mmol/l correlating with
achievement of target glycated haemoglobin (HbA1c)
of <7 % as per the [9] criteria. Overall 66 patients were
enrolled to participate in the study. Forty-four other
subjects without diabetes were prospectively recruited
as controls within the same study period. The control
group were aged-matched volunteers accompanying
cases to the diabetic center. The same biochemical cri-
teria were examined in the controls subjects. Controls
had fasting plasma glucose <5.6 mmol/L or two-hour
glucose during OGTT < 7.8 mmol/L. Second, venous
blood samples were collected from diabetics and non-
diabetic controls and analyzed for various haemato-
logical changes.
Exclusion criteria
Pregnant and lactating women were excluded from the
study. Patients with medical conditions such as infec-
tions, cerebrovascular diseases, ischaemic heart disease
and malignancies excluded from the study. Other exclu-
sion criteria were smoking and alcoholism.
Study conduct
Haematological indices and fasting glucose analysis
After an overnight fast, 5 ml of venous blood was col-
lected from each participant. Three milliliters of which
was put into an EDTA tube for haematological indices
and SOD activity analysis and 2 ml was put into a fluor-
ide tube for fasting plasma glucose (FPG) analysis using
an automated analyzer (A25 Biosytems, Canada). The
haematological indices were determined by performing a
full blood count (FBC) using an automated haematology
analyzer (Sysmex KX-21 N, Germany). The following
haematological indices were assessed: Haemoglobin,
Haematocrit, Mean cell volume, white cell count (in-
cluding lymphocyte and neutrophil count); platelet
count. The rest of the blood sample was then centri-
fuged at 4000 rpm for 10 min to separate plasma from
the red blood cells. The stored red blood cells were used
for further work involving SOD activity determination.
Measurement of sod activity as an index of oxidative stress
status
Briefly, the SOD activity levels were determined by using
SOD Assay kit (Cayman Chemicals, Michigan, USA).
Whole blood obtained by venipuncture from the partici-
pants was centrifuged at 4000 rpm for 10mins, and
plasma carefully separated. Two hundred and fifty (250)
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cells was lysed with thousand (1,000) microliters of ice-
cold deionized distilled water and centrifuged at 6,000 rpm
for 20 min. Thousand microliters (1000 μl) of the super-
natant (erythrocyte lysate) was collected for assay and
stored on ice. The supernatant fluid was then diluted
by a factor of 100 with sample buffer, and 10 μl of the
diluted solution used to assay Cu/ZnSOD (Copper/Zinc
Superoxide dismutase) activity as described by the kit
manufacturer.
Data analysis
Data obtained was put into a database and analyzed sta-
tistically using Statistical Package for Social Sciences
(SPSS) 20.0 software for windows. Summary statistics
was presented using the descriptive statistics of mean
and standard deviation for numerical variables and
proportions for categorical variables. Independent t-test
or analysis of variance (ANOVA) and Pearson’s correl-
ation analysis were used to determine the mean differ-
ences and the correlation between oxidative stress and
haematological parameters respectively. A p-value less
than 0.05 was interpreted as significant.
Results
Demographic and clinical data
One hundred and ten (110) participants were recruited
to the study — consisting of 66 subjects with diabetes
(cases) and 44 subjects without diabetes (controls). For
both cases and controls, over 80 % were made up of
females. The mean ages for cases and controls were
55.85 ± 8.82 years and 50.32 ± 12.44 years respectively
(Table 1). Fasting plasma glucose concentration was higher
among the cases compared with the controls (p = 0.000).
In this study, cases were mostly on stable doses of Gliben-
clamide, Metformin and Insulin in various combinations.




Mean Age (years) ± SD
FBG (mmol/L) ± SD
Duration of Diabetes (years) ± SD
Anti-hypertensive drugs
Patients on Metformin only
Patients on Metformin plus other drugs
Patients Metformin plus Glibenclamide
Patients Metformin plus Insulin
Patients on other drugs aside metformin
SD, standard deviationcombination of Glibenclamide and Metformin while
22.7 % (n = 15) used both metformin and Insulin. About
40 % (n = 26) of cases were on metformin alone for the
management of diabetes. Overall, 9 diabetic patients (n =
13.6) used other diabetic drugs aside metformin.
Oxidative stress
Table 2 shows the SOD activity values analyzed on blood
samples obtained from the participants. Superoxide dis-
mutase activity among case patients (285.44 ± 114.36 U/ml)
did not significantly differ (p-value 0.144) from those ob-
served within the control group (319.79 ± 126.12 U/ml).
When SOD activity was compared within case patients, we
observed homogeneity in SOD activity values between pa-
tients using metformin only, those on diabetic medications
aside metformin, and those taking metformin in combina-
tions with other drugs (degree of freedom, 2; F-value,
0.261; p-value, 0.771).
Haematological parameters
Table 3 compares various haematological indices be-
tween diabetic patients and the control cohort. There
was a significantly higher (p = 0.023) total white blood
cell count in the diabetes cohort compared to control sub-
jects. There did not appear to be differences in lymphocyte
count, neutrophil count, red cell count, platelet count,
haemoglobin and haematocrit levels between diabetic
cases and the control group.
Correlation between SOD and haematological parameters
In Table 4, association between SOD activity and haem-
atological changes are compared. Higher neutrophil
activity seemed to weakly correlate with increased SOD
activity (R = 0.249; R2 = 6.2 %; p < 0.049). None of the
other measured haematological indices correlated with
SOD activity values. Similarly, there did not appear to be
correlation between FBG and SOD activity.parison to controls
Number of cases Number of controls
66 44
55/11 38/6
55.85 ± 8.82 50.32 ± 12.44
8.34 ± 3.47 4.75 ± 0.55
10.67 ± 7.53 -
39 (59.0 %) 8 (18.1 %)
26 (39.4 %) -
57 (83.6 %) -
16 (24.2 %) -
15 (22.7 %) -
9 (13.6) -
Table 2 Superoxide dismutase activity in diabetic subjects in comparison to controls
Parameters Cases ± SD Controls ± SD p value
Total SOD Activity (U/ml) 285.44 ± 114.36 319.79 ± 126.12 0.144
SOD Activity (U/ml) of cases on Metformin onlya 274.81 ± 122.73 - a*b*c =0.771
SOD Activity (U/ml) of cases on Metformin and other drugsb 281.75 ± 111.91 - Post hoc:
SOD Activity (U/ml) of cases on other drugs aside Metforminc 307.98 ± 133.40 a*b =0.824 ;
a*c =0.499;
b*c =0.5265
FBG- Fasting blood glucose; SOD-Superoxide dismutase; SD, standard deviation
Table 4 Correlation between SOD Activity Levels and
haematological indices
Pearson’s Correlations R p value
FBG and SOD Levels −0.044 0.727
WBC and SOD Levels 0.047 0.714
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Oxidative stress is increasingly being reported as a
widely accepted participant in the progression of dia-
betes and its complications. In this study, the mean
fasting plasma glucose level of patients with diabetes
was 8.34 mmol/l (Table 2) — significantly higher than
the recommended target FPG indicative of good gly-
caemic control (3.9 – 7.2 mmol/l) — and confirming
that the cases were more likely to be exposed to persist-
ent hyperglycaemia [10, 11]. Persistent hyperglycaemia
in diabetes is often accompanied by increased produc-
tion of free radicals or impaired antioxidant defenses [7,
12–14]. In the present study, the SOD activity tended to
be lower in the diabetes group (p > 0.05 however) com-
pared to controls but the trend did not achieve statistical
significance. Majority of the diabetic cases were on met-
formin (either as monotherapy or in combination with
other medications such as insulin) and most likely may
have benefited from their antioxidant properties. Metfor-
min, a drug taken to control diabetes has been reported
to possess antioxidant properties by inhibiting gener-
ation of reactive oxidative species in diabetes and
thereby reducing oxidative stress [15]. A reduction in
ROS levels in human leukocytes due to metformin admin-
istration by direct scavenging of the free radicals has been
reported by Bonnefont-Rousselot et al. [16]. Other
hypoglycaemic agents such as insulin have also been
shown to have similar impact on oxidative stress [17].Table 3 Full blood count of study participants
Parameters Cases ± SD Controls ± SD p value
WBC (x103/μL) 5.87 ± 1.76 5.25 ± 1.05 0.023*
RBC (x106/μL) 4.48 ± 0.60 4.57 ± 0.54 0.426
HGB (g/dL) 12.29 ± 1.50 12.60 ± 1.30 0.273
HCT (%) 38.77 ± 5.01 39.32 ± 3.29 0.485
Platelets (x103/μL) 233.89 ± 62.81 221.05 ± 59.62 0.286
NEU (%) 46.73 ± 14.44 47.89 ± 10.64 0.649
LYM (%) 44.33 ± 14.43 43.80 ± 9.50 0.816
WBC-White blood cells; RBC-Red blood cells; HGB-Haemoglobin; HCT-Haematocrit;
NEU-Neutrophils; LYM-Lymphocytes (* p-value <0.05 is considered significant);
SD, standard deviationChanges in haematological indices, except for the
higher WBC trend in the diabetes group, were similar in
both study cohorts. It is noteworthy that the high white
cell count in the diabetes group is in keeping with the
increased oxidative stress triggered by the high levels of
hyperglycaemia observed in this cohort. Polymorpho-
nuclear and mononuclear leukocytes can be activated by
advanced glycation end-products and cytokines in a state
of hyperglycaemia [18].
Our study reports of SOD activity that significantly al-
beit weakly correlated with neutrophil count. The obser-
vation agree well with findings by Kotani and Sakane
[19] who worked on diacron reactive oxygen metabolites
(d-ROMs) as clinical markers for evaluation of total
oxidative burden. Their work showed positive correlation
between neutrophil counts and d-ROMs levels in asymp-
tomatic female subjects. Neutrophils secrete a variety of
inflammatory cytokines such as interleukin-6 which trig-
ger an increase in oxidative stress [20, 21]. Oxidative stress
also activates the inflammatory pathway with leukotriene
B4 which attract neutrophils to inflammatory sites further
generating oxidative stress [19, 22].RBC and SOD Levels 0.113 0.375
HGB and SOD Levels 0.028 0.824
HCT and SOD Levels 0.002 0.99
MCV and SOD Levels −0.092 0.469
MCH and SOD Levels −0.078 0.542
MCHC and SOD Levels 0.004 0.975
PLT and SOD Levels 0.235 0.061
NEU(%) and SOD Levels 0.249* 0.049*
LYM(%) and SOD Levels −0.208 0.099
*Correlation is significant at p value < 0.05 (2-tailed)
WBC-White blood cells; RBC-Red blood cells; HGB-Haemoglobin; HCT-Haematocrit;
NEU-Neutrophils; LYM-Lymphocytes; FBG- Fasting blood glucose; SOD- Superoxide
dismutase; PLT-platelet count; NEU-neutrophil count; LYM- lymphocyte count;
MCV- Mean corpuscular volume; MCH- Mean corpuscular haemoglobin; MCHC-
Mean corpuscular haemoglobin concentration
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should be discussed briefly. First, the limited sample size.
This could partly explain our findings of similar SOD ac-
tivity values in the diabetic and control cohorts. A more
large-scale survey is likely to be more accurate with little
bias for unequal drug preferences. Another noteworthy
limitation to our study is its cross-sectional design
involving single measurement of haematological indices
which may not demonstrate a temporal relationship with
oxidative stress. Additionally intercurrent infections which
were not actively sought for by our study cannot be
completely excluded and might have potentially exerted
confounding effects on the haematological indices.
Conclusion
In conclusion, we report similar SOD activity and for
that matter similar oxidative stress levels in diabetic and
non-diabetic adults. Oxidative stress as measured by
SOD activity did not appear to correlate with FBG and
several other haematological parameters. Further study
would be required to investigate the relationship be-
tween these haematological indices and diabetic micro
and macrovascular complications in our population.
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